Search by Drug Name or NDC
NDC 00597-0160-61 Spiriva Respimat 1.562 ug/1 Details
Spiriva Respimat 1.562 ug/1
Spiriva Respimat is a RESPIRATORY (INHALATION) SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is TIOTROPIUM BROMIDE ANHYDROUS.
MedlinePlus Drug Summary
Tiotropium is used to prevent wheezing, shortness of breath, coughing, and chest tightness in patients with chronic obstructive pulmonary disease (COPD, a group of diseases that affect the lungs and airways) such as chronic bronchitis (swelling of the air passages that lead to the lungs) and emphysema (damage to air sacs in the lungs). Tiotropium is in a class of medications called bronchodilators. It works by relaxing and opening the air passages to the lungs to make breathing easier.
Related Packages: 00597-0160-61Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tiotropium Oral Inhalation
Product Information
| NDC | 00597-0160 |
|---|---|
| Product ID | 0597-0160_bf4399ac-101f-486b-8c8f-d48dffe32d63 |
| Associated GPIs | 44100080103410 |
| GCN Sequence Number | 074813 |
| GCN Sequence Number Description | tiotropium bromide MIST INHAL 1.25 MCG INHALATION |
| HIC3 | B61 |
| HIC3 Description | ANTICHOLINERGICS, ORALLY INHALED LONG ACTING |
| GCN | 39587 |
| HICL Sequence Number | 024024 |
| HICL Sequence Number Description | TIOTROPIUM BROMIDE |
| Brand/Generic | Brand |
| Proprietary Name | Spiriva Respimat |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tiotropium bromide inhalation spray |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | RESPIRATORY (INHALATION) |
| Active Ingredient Strength | 1.562 |
| Active Ingredient Units | ug/1 |
| Substance Name | TIOTROPIUM BROMIDE ANHYDROUS |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA207070 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00597-0160-61 (00597016061)
| NDC Package Code | 0597-0160-61 |
|---|---|
| Billing NDC | 00597016061 |
| Package | 1 CARTRIDGE in 1 CARTON (0597-0160-61) / 60 SPRAY, METERED in 1 CARTRIDGE |
| Marketing Start Date | 2015-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 126.158 |
| Pricing Unit | GM |
| Effective Date | 2024-01-01 |
| NDC Description | SPIRIVA RESPIMAT 1.25 MCG INH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis